Skip to main content
. 2020 Jul 11;12(7):1867. doi: 10.3390/cancers12071867

Figure 3.

Figure 3

Overall survival time in patients with HCC who did or did not require DLSAE. Kaplan-Meier curves for overall survival according to DLSAE or no DLSAE in patients with HCC treated with LEN. The solid line indicates the no DLSAE group. The dotted line indicates the DLSAE group. Abbreviations: HCC, hepatocellular carcinoma; DLSAE, discontinuation of lenvatinib due to severe adverse events; LEN, lenvatinib.